OVERVIEW
This free activity consists of two Lecture Presentations, a Learning Assessment, and an Evaluation form. The content of this virtual lecture is derived from a satellite symposium presented on May 17, 2008, in Philadelphia, Pennsylvania.

MEDIUM: Virtual Lecture
INTERNET RELEASE DATE: August 8, 2008
CE AVAILABLE UNTIL: February 8, 2010

Estimated time to complete this activity: 2 hours

---

TARGET AUDIENCE
This activity has been designed to meet the educational needs of nurses, social workers, and other healthcare professionals involved in the care of patients in underserved populations who would benefit from clinical trials.

---

ACTIVITY PURPOSE
It is critical to understand the causes and impact of health disparities and the disproportionate burden of cancer among underserved populations. Early access to information, resources and the best possible treatments, including clinical trials, is key to reducing and eliminating disparities in cancer care.

This activity will provide an overview of cancer health disparities and address barriers to recruitment and retention of underserved populations in cancer clinical trials. Healthcare professionals will be provided with tools and strategies to offer all patients access to information, support, early intervention and cutting-edge treatments. Community-based participatory research (CBPR), a partnership intervention, will be discussed along with best practices in education and support services for underserved populations.

---

EDUCATIONAL OBJECTIVES
After completing this activity, the participant will be better able to:

• Describe the causes and impact of cancer health disparities
• Discuss the importance of early interventions and access to care
• Discuss challenges of recruitment and retention of underserved patients into cancer clinical trials
• Identify education and support services for underserved cancer patients
• Explain community-based participatory research (CBPR) as a partnership intervention
• Apply strategies to enhance treatment access and trial participation for underserved patients

---

METHOD OF PARTICIPATION
To complete this activity and receive a Statement of Credit, participants must:

1. Review all contents of this activity
2. Complete and submit the Learning Assessment and Evaluation form
3. Score at least 70% on the Learning Assessment

---

CONTINUING EDUCATION INFORMATION

NURSES AND SOCIAL WORKERS
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society, provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (www.aswb.org) through the Approved Continuing Education program. LLS maintains responsibility for the program. Social workers participating in this course will receive 2.0 CE clock hours. Licensed social workers should contact their individual jurisdictional board to review current continuing education requirements.

---

FACULTY
Bertie Ford, RN, MS, AOCN^®
Bertie Ford, RN, MSN, AOCN^® is a Clinical Oncology Specialist for Genentech BioOncology in the field of targeted therapies, health disparities and minority recruitment for clinical trials. She has managed cancer research programs at the James Cancer Hospital and Grant Riverside Hospital and was co-chair of the Participant Navigation Team of the Eliminating Disparities in Clinical Trials (EDICT) project. She currently serves on the Board of Directors for the Oncology Nursing Society (ONS) as a Director at Large. Ms. Ford is also the ONS liaison to Sisters Network, a national organization for African American women with breast cancer. Ms. Ford was the recipient of the 2003 Pearl Moore "Making a Difference" Award for excellence in oncology nursing. She is editor and co-author of the second edition of the Manual for Clinical Trials Nursing.

Mary Jackson Scroggins, MA
Mary Jackson Scroggins, MA, is the co-founder and president of the Board of Directors of the national organization, In My Sister's Care, and serves on several committees including the Gynecologic Oncology Group's Patient Advocate Committee and the Ovarian Cancer National Alliance Outreach Task Force. She is also a faculty member of the AACR/ASCO Workshop on Methods in Clinical Cancer Research. Ms. Scroggins participated continuously in the Department of Defense Ovarian Cancer Research Program from its inception in 1997 through 2006, and was previously co-chair of the Community Involvement-Focused Team of the Eliminating Disparities in Clinical Trials (EDICT) project. She has also published numerous essays and articles on cancer survivorship and health disparities. Ms. Scroggins is currently pursuing a doctoral degree in Human Development.

---

DISCLOSURE OF CONFLICTS OF INTEREST
All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to the activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. Faculty also are expected to disclose any unlabeled or investigational uses of products discussed in their presentations.

Bertie Ford, RN, MS, AOCN^®, has asked that we advise participants in this activity that she has an affiliation with Genentech BioOncology (Employee).

Mary Jackson Scroggins, MA, has asked that we advise participants in this activity that she has no affiliations at this time.

---

STATEMENT OF SUPPORT
This program is supported by Cooperative Agreement Number U58/CCU224200-03 from the Centers for Disease Control and Prevention. Its content is solely the responsibility of The Leukemia & Lymphoma Society and does not necessarily represent the official views of the Centers for Disease Control and Prevention.

---

FEE INFORMATION
There is no fee for this educational activity.

---

QUESTIONS AND TECHNICAL ASSISTANCE
For questions regarding the content of this activity, contact the Information Resource Center at 800-955-4572. Visit the Society's Web site at www.LLS.org. For technical assistance, contact jungsen@rmcom.net.

---

SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - Mozilla Firefox 1.0+
• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+
• Additional Requirements
  - Windows Media Player
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

 

 

RMEI Privacy Statement

Grievances or assistance for people with disabilities, please contact the LLS Information Resource Center (IRC) at (800) 955-4572.